Victory Capital Management Inc Astrazeneca PLC Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Victory Capital Management Inc holds 262,553 shares of AZN stock, worth $16.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

262,553

Previous 264,451 0.72%

Holding current value

$16.9 Million

Previous $20.6 Million 0.8%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$76.67 - $87.62 $145,519 - $166,302	-1,898 Reduced 0.72%	262,553 $20.5 Million
Q2 2024 Aug 05, 2024	SELL	$66.81 - $80.83 $82,844 - $100,229	-1,240 Reduced 0.47%	264,451 $20.6 Million
Q1 2024 May 03, 2024	SELL	$61.03 - $69.57 $575,329 - $655,836	-9,427 Reduced 3.43%	265,691 $18 Million
Q4 2023 Feb 05, 2024	BUY	$61.89 - $69.28 $32,492 - $36,372	525 Added 0.19%	275,118 $18.5 Million
Q3 2023 Nov 06, 2023	BUY	$64.85 - $71.7 $3.35 Million - $3.71 Million	51,687 Added 23.19%	274,593 $18.6 Million
Q2 2023 Jul 27, 2023	SELL	$69.91 - $75.81 $894,148 - $969,609	-12,790 Reduced 5.43%	222,906 $16 Million
Q1 2023 May 02, 2023	BUY	$63.15 - $71.6 $2.29 Million - $2.6 Million	36,313 Added 18.21%	235,696 $16.4 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $2.06 Million - $2.68 Million	-38,007 Reduced 16.01%	199,383 $13.5 Million
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $1.54 Million - $2 Million	28,344 Added 13.56%	237,390 $16.1 Million
Q3 2022 Nov 02, 2022	BUY	$53.02 - $135.75 $1.83 Million - $4.69 Million	34,569 Added 19.81%	209,046 $11.5 Million
Q2 2022 Aug 01, 2022	BUY	$59.26 - $71.14 $84,030 - $100,876	1,418 Added 0.82%	174,477 $11.5 Million
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $5.17 Million - $6.23 Million	92,808 Added 115.65%	173,059 $11.5 Million
Q4 2021 Feb 07, 2022	BUY	$54.02 - $63.83 $2.17 Million - $2.56 Million	40,087 Added 99.81%	80,251 $4.68 Million
Q3 2021 Nov 02, 2021	SELL	$55.56 - $60.79 $322,136 - $352,460	-5,798 Reduced 12.61%	40,164 $2.41 Million
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $707,851 - $879,771	-14,619 Reduced 24.13%	45,962 $2.75 Million
Q1 2021 May 04, 2021	BUY	$47.16 - $54.44 $136,575 - $157,658	2,896 Added 5.02%	60,581 $3.01 Million
Q4 2020 Feb 01, 2021	BUY	$48.52 - $58.02 $2.8 Million - $3.35 Million	57,685 New	57,685 $2.88 Million
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $16.6 Million - $18.8 Million	-412,544 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $162,913 - $182,141	4,370 Added 1.07%	412,544 $17 Million
Q4 2018 Feb 05, 2019	BUY	$36.86 - $41.49 $15 Million - $16.9 Million	408,174 New	408,174 $15.5 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Astrazeneca PLC Transaction History